|
US4920132A
(en)
*
|
1987-11-03 |
1990-04-24 |
Rorer Pharmaceutical Corp. |
Quinoline derivatives and use thereof as antagonists of leukotriene D4
|
|
US5324743A
(en)
*
|
1992-12-10 |
1994-06-28 |
Eli Lilly And Company |
Leukotriene B4 antagonists
|
|
GB2279659B
(en)
|
1993-07-05 |
1998-04-22 |
Merck Patent Gmbh |
Liquid crystalline material
|
|
CZ220498A3
(cs)
|
1996-01-17 |
1998-11-11 |
Novo Nordisk A/S |
Deriváty 1,2,4-thiadiazinu a 1,4-thiazinu, příprava a použití
|
|
JP2002503202A
(ja)
|
1996-02-02 |
2002-01-29 |
メルク エンド カンパニー インコーポレーテッド |
抗糖尿病薬
|
|
CA2244831A1
(en)
|
1996-02-02 |
1997-08-07 |
John T. Olson |
Method of treating diabetes and related disease states
|
|
CA2245524A1
(en)
|
1996-02-02 |
1997-08-07 |
Wei Han |
Antidiabetic agents
|
|
ATE236137T1
(de)
|
1996-02-02 |
2003-04-15 |
Merck & Co Inc |
Heterocyclische verbindungen als antidiabetische mittel und für die behandlung von fettleibigkeit
|
|
AU1856997A
(en)
|
1996-02-02 |
1997-08-22 |
Merck & Co., Inc. |
Method for raising hdl cholesterol levels
|
|
DE122009000079I2
(de)
|
1996-08-30 |
2011-06-16 |
Novo Nordisk As Novo Alle |
Glp-1 derivate
|
|
AU719663B2
(en)
|
1996-12-23 |
2000-05-11 |
Merck & Co., Inc. |
Antidiabetic agents
|
|
WO1999001423A1
(en)
|
1997-07-01 |
1999-01-14 |
Novo Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
AU757693B2
(en)
|
1997-07-16 |
2003-03-06 |
Novo Nordisk A/S |
Fused 1,2,4-thiadiazine derivatives, their preparation and use
|
|
AU8355998A
(en)
|
1997-07-24 |
1999-02-16 |
Yamanouchi Pharmaceutical Co., Ltd. |
Medicinal compositions with cholesterol-lowering effect
|
|
AU9696198A
(en)
|
1997-10-17 |
1999-05-10 |
Aventis Pharmaceuticals Products Inc. |
Therapeutic uses of quinoline derivatives
|
|
JP2003500432A
(ja)
*
|
1999-06-01 |
2003-01-07 |
ザ・ユニバーシティ・オブ・テキサス・サウスウエスタン・メディカル・センター |
ジフェニルエーテル誘導体を用いて脱毛症を処置する方法
|
|
GB9914977D0
(en)
|
1999-06-25 |
1999-08-25 |
Glaxo Group Ltd |
Chemical compounds
|
|
TWI262185B
(en)
|
1999-10-01 |
2006-09-21 |
Eisai Co Ltd |
Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives
|
|
AU7995300A
(en)
|
1999-10-05 |
2001-05-10 |
Bethesda Pharmaceuticals, Inc. |
Dithiolane derivatives
|
|
AU1303301A
(en)
|
1999-11-10 |
2001-06-06 |
Takeda Chemical Industries Ltd. |
Body weight gain inhibitors
|
|
IL148579A0
(en)
|
1999-11-11 |
2002-09-12 |
Lilly Co Eli |
Oncolytic combinations for the treatment of cancer
|
|
JP2003523336A
(ja)
|
2000-02-18 |
2003-08-05 |
メルク エンド カムパニー インコーポレーテッド |
糖尿病及び脂質障害のためのアリールオキシ酢酸
|
|
MXPA02007603A
(es)
|
2000-03-09 |
2003-02-24 |
Aventis Pharma Gmbh |
Usos terapeuticos de mediadores ppar.
|
|
US6448293B1
(en)
*
|
2000-03-31 |
2002-09-10 |
Pfizer Inc. |
Diphenyl ether compounds useful in therapy
|
|
JP2001354671A
(ja)
|
2000-04-14 |
2001-12-25 |
Nippon Chemiphar Co Ltd |
ペルオキシソーム増殖剤応答性受容体δの活性化剤
|
|
FR2812876B1
(fr)
*
|
2000-08-08 |
2002-09-27 |
Galderma Res & Dev |
Nouveaux composes bi-aromatiques activateurs des recepteurs de type ppar-gamma et leur utilisation dans des compositions cosmetiques ou pharmaceutiques
|
|
JP4790969B2
(ja)
|
2000-08-11 |
2011-10-12 |
日本ケミファ株式会社 |
ペルオキシソーム増殖剤応答性受容体δの活性化剤
|
|
US6630504B2
(en)
*
|
2000-08-31 |
2003-10-07 |
Pfizer Inc. |
Phenoxyphenylheterocyclyl derivatives as SSRIs
|
|
GB0024361D0
(en)
|
2000-10-05 |
2000-11-22 |
Glaxo Group Ltd |
Medicaments
|
|
JPWO2002046154A1
(ja)
|
2000-12-05 |
2004-04-08 |
日本ケミファ株式会社 |
ペルオキシソーム増殖剤応答性受容体δの活性化剤
|
|
GB0031107D0
(en)
|
2000-12-20 |
2001-01-31 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0031109D0
(en)
|
2000-12-20 |
2001-01-31 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0031103D0
(en)
|
2000-12-20 |
2001-01-31 |
Glaxo Group Ltd |
Chemical compounds
|
|
ATE433964T1
(de)
|
2000-12-28 |
2009-07-15 |
Takeda Pharmaceutical |
Alkansäurederivate, verfahren zu deren herstellung und deren verwendung
|
|
EP1357914A2
(en)
|
2001-02-02 |
2003-11-05 |
SmithKline Beecham Corporation |
Treatment of ppar mediated diseases
|
|
JP4157381B2
(ja)
|
2001-03-23 |
2008-10-01 |
日本ケミファ株式会社 |
ペルオキシソーム増殖剤応答性受容体の活性化剤
|
|
US7253178B2
(en)
|
2001-03-28 |
2007-08-07 |
Eisai Co., Ltd. |
Carboxylic acids
|
|
WO2002080899A1
(fr)
|
2001-03-30 |
2002-10-17 |
Eisai Co., Ltd. |
Agent de traitement de maladie digestive
|
|
TWI311133B
(en)
|
2001-04-20 |
2009-06-21 |
Eisai R&D Man Co Ltd |
Carboxylic acid derivativeand the salt thereof
|
|
WO2002098840A1
(en)
|
2001-06-04 |
2002-12-12 |
Eisai Co., Ltd. |
Carboxylic acid derivative and medicine comprising salt or ester of the same
|
|
FR2826574B1
(fr)
|
2001-06-29 |
2005-08-26 |
Oreal |
Compositions contenant un derive d'hydroxydiphenyl ether inhibant le developpement des odeurs corporelles
|
|
EP1414778A1
(en)
*
|
2001-07-30 |
2004-05-06 |
Novo Nordisk A/S |
Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc.
|
|
WO2003016291A1
(en)
|
2001-08-10 |
2003-02-27 |
Nippon Chemiphar Co., Ltd. |
ACTIVATOR FOR PEROXISOME PROLIFERATOR-RESPONSIVE RECEPTOR δ
|
|
US7371777B2
(en)
|
2001-08-17 |
2008-05-13 |
Eisai Co., Ltd. |
Cyclic compound and PPAR agonist
|
|
IL160845A0
(en)
|
2001-09-14 |
2004-08-31 |
Tularik Inc |
Linked biaryl compounds
|
|
MXPA04003398A
(es)
|
2001-10-12 |
2004-11-22 |
Nippon Chemiphar Co |
Activador para el receptor o activado con el proliferador de peroxisoma.
|
|
KR20050036876A
(ko)
|
2001-10-17 |
2005-04-20 |
노보 노르디스크 에이/에스 |
디카르복실산 유도체, 그것의 제제 및 치료에의 사용
|
|
DE10151390A1
(de)
|
2001-10-18 |
2003-05-08 |
Bayer Ag |
Essigsäurederivate
|
|
JP2003171275A
(ja)
|
2001-12-11 |
2003-06-17 |
Sumitomo Pharmaceut Co Ltd |
ＰＰＡＲδアゴニスト
|
|
US6648293B1
(en)
*
|
2001-12-20 |
2003-11-18 |
Braeside Plastics Corporation |
Foldable display container and method for assembling the same
|
|
WO2003072100A1
(en)
|
2002-02-25 |
2003-09-04 |
Eli Lilly And Company |
Peroxisome proliferator activated receptor modulators
|
|
JP4383177B2
(ja)
|
2002-03-01 |
2009-12-16 |
スミスクライン ビーチャム コーポレーション |
ｈＰＰＡＲ活性化剤
|
|
US20030207924A1
(en)
|
2002-03-07 |
2003-11-06 |
Xue-Min Cheng |
Compounds that modulate PPAR activity and methods of preparation
|
|
US6867224B2
(en)
|
2002-03-07 |
2005-03-15 |
Warner-Lambert Company |
Compounds that modulate PPAR activity and methods of preparation
|
|
US6833380B2
(en)
|
2002-03-07 |
2004-12-21 |
Warner-Lambert Company, Llc |
Compounds that modulate PPAR activity and methods of preparation
|
|
US6875780B2
(en)
*
|
2002-04-05 |
2005-04-05 |
Warner-Lambert Company |
Compounds that modulate PPAR activity and methods for their preparation
|
|
DE10222034A1
(de)
|
2002-05-17 |
2003-11-27 |
Bayer Ag |
Tetrahydroisochinolin-Derivate
|
|
GB0214149D0
(en)
|
2002-06-19 |
2002-07-31 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0214254D0
(en)
|
2002-06-20 |
2002-07-31 |
Glaxo Group Ltd |
Chemical compounds
|
|
DE10229777A1
(de)
|
2002-07-03 |
2004-01-29 |
Bayer Ag |
Indolin-Phenylsulfonamid-Derivate
|
|
JPWO2004007439A1
(ja)
*
|
2002-07-10 |
2005-11-10 |
住友製薬株式会社 |
ビアリール誘導体
|
|
US7816385B2
(en)
*
|
2002-12-20 |
2010-10-19 |
High Point Pharmaceuticals, Llc |
Dimeric dicarboxylic acid derivatives, their preparation and use
|
|
AU2003287912A1
(en)
|
2002-12-20 |
2004-07-14 |
Novo Nordisk A/S |
Dicarboxylic acid derivatives as ppar-agonists
|
|
US20060241157A1
(en)
|
2003-01-06 |
2006-10-26 |
Conner Scott E |
Heterocyclic ppar modulators
|
|
DE10300099A1
(de)
|
2003-01-07 |
2004-07-15 |
Bayer Healthcare Ag |
Indol-Phenylsulfonamid-Derivate
|
|
AU2004210711B2
(en)
|
2003-02-12 |
2010-07-08 |
Transtech Pharma, Inc. |
Substituted azole derivatives as therapeutic agents
|
|
CN1751037A
(zh)
|
2003-02-14 |
2006-03-22 |
伊莱利利公司 |
作为ppar调节剂的磺酰胺衍生物
|
|
JPWO2004080943A1
(ja)
|
2003-03-11 |
2006-06-08 |
小野薬品工業株式会社 |
シンナミルアルコール誘導体化合物およびその化合物を有効成分として含有する薬剤
|
|
EP1602642A4
(en)
|
2003-03-13 |
2006-11-08 |
Ono Pharmaceutical Co |
IMINO ETHER-DERIVED COMPOUNDS AND MEDICAMENTS COMPRISING SAID COMPOUNDS AS ACTIVE INGREDIENT
|
|
US20060258683A1
(en)
|
2003-04-07 |
2006-11-16 |
Liu Kevin |
Para-sulfonyl substituted phenyl compounds as modulators of ppars
|
|
CN1791409A
(zh)
|
2003-04-17 |
2006-06-21 |
凯利普西斯公司 |
作为 p p a r调节剂的 ( 3 －{ 3'－ [ ( 2 , 4 －双 －三氟甲基 －苄基)－ ( 5 －乙基 －嘧啶 － 2 －基 )－氨基 ]－丙氧基} －苯基) －乙酸及相关化合物以及治疗代谢失调的方法
|
|
US7244763B2
(en)
|
2003-04-17 |
2007-07-17 |
Warner Lambert Company Llc |
Compounds that modulate PPAR activity and methods of preparation
|
|
WO2004099170A2
(en)
|
2003-04-30 |
2004-11-18 |
The Institutes For Pharmaceutical Discovery, Llc |
Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
|
|
WO2005054176A1
(en)
*
|
2003-11-25 |
2005-06-16 |
Eli Lilly And Company |
Peroxisome proliferator activated receptor modulators
|
|
AU2005231358A1
(en)
|
2004-04-01 |
2005-10-20 |
Aventis Pharmaceuticals Inc. |
Use of PPR delta agonists for treating demyelinating diseases
|
|
CN100516065C
(zh)
|
2004-04-01 |
2009-07-22 |
安万特药物公司 |
1,3,4-二唑-2-酮作为PPAR-δ调节剂
|
|
AU2005230838A1
(en)
|
2004-04-01 |
2005-10-20 |
Aventis Pharmaceuticals Inc. |
1,3,4-oxadiazol-2-ones as PPAR delta
|
|
ES2352085T3
(es)
*
|
2004-05-05 |
2011-02-15 |
High Point Pharmaceuticals, Llc |
Nuevos compuestos, su preparación y uso.
|
|
KR20070026503A
(ko)
|
2004-05-14 |
2007-03-08 |
아이알엠 엘엘씨 |
Ｐｐａｒ 조절제로서의 화합물 및 조성물
|
|
EP1999098A2
(en)
|
2006-03-09 |
2008-12-10 |
High Point Pharmaceuticals, LLC |
Compounds that modulate ppar activity, their preparation and use
|